Login / Signup

Multiple Myeloma: Current Clinical Landscape and Compounding Costs.

Kelsey BeckTyler SandahlSikander AilawadhiNandita KheraChelsee Jo Jensen
Published in: Current hematologic malignancy reports (2023)
With the recent passing of the Inflation Reduction Act (IRA), we postulate how costs may be impacted and debate future policy initiatives that may result in sustainability. The IRA will impact drug pricing and likely reduce the costs of some treatments used in MM; there is still a lot of room for policy reform to reduce financial toxicity to patients and prevent depletion of the Medicare trust fund.
Keyphrases